Overexpression of NCAPH is upregulated and predicts a poor prognosis in prostate cancer

  • Authors:
    • Feilun Cui
    • Jianpeng Hu
    • Zhipeng Xu
    • Jian Tan
    • Huaming Tang
  • View Affiliations

  • Published online on: April 17, 2019     https://doi.org/10.3892/ol.2019.10260
  • Pages: 5768-5776
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Prostate cancer (PCa) is one of the most frequently diagnosed types of cancer worldwide. However, there remains a lack of accurate biomarkers to predict the outcome of PCa. Non‑SMC condensin I complex subunit H (NCAPH) encodes a regulatory subunit of the non‑structural maintenance of chromosomes condensin I complex. The present study aimed to investigate whether NCAPH may be a novel diagnostic marker for PCa by analyzing public datasets, including GSE17951, GSE55945 and a dataset from The Cancer Genome Atlas. The current results, to the best of our knowledge, demonstrated for the first time that NCAPH is significantly upregulated in PCa. Furthermore, it was identified that NCAPH expression is higher in stage T3/T4 and N1 PCa samples compared with stage T2 and N0 PCa samples, respectively. Kaplan‑Meier analysis demonstrated that overexpression of NCAPH is associated with poor survival of patients with PCa. Bioinformatics analysis revealed that NCAPH is involved in regulating the PCa cell cycle by interacting with a number of proteins, including non‑SMC condensin I complex subunit D2, non‑SMC condensin I complex subunit G, structural maintenance of chromosomes 4, structural maintenance of chromosomes 2, Aurora kinase A, Aurora kinase B, cyclin‑dependent kinase 1, H2A histone family member Z, POC1 centriolar protein A and histone cluster 2 H2A family member C. In summary, the present results suggest NCAPH may be a novel and beneficial diagnostic and therapeutic target in PCa.
View Figures
View References

Related Articles

Journal Cover

June-2019
Volume 17 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos
Cui F, Hu J, Xu Z, Tan J and Tang H: Overexpression of NCAPH is upregulated and predicts a poor prognosis in prostate cancer. Oncol Lett 17: 5768-5776, 2019
APA
Cui, F., Hu, J., Xu, Z., Tan, J., & Tang, H. (2019). Overexpression of NCAPH is upregulated and predicts a poor prognosis in prostate cancer. Oncology Letters, 17, 5768-5776. https://doi.org/10.3892/ol.2019.10260
MLA
Cui, F., Hu, J., Xu, Z., Tan, J., Tang, H."Overexpression of NCAPH is upregulated and predicts a poor prognosis in prostate cancer". Oncology Letters 17.6 (2019): 5768-5776.
Chicago
Cui, F., Hu, J., Xu, Z., Tan, J., Tang, H."Overexpression of NCAPH is upregulated and predicts a poor prognosis in prostate cancer". Oncology Letters 17, no. 6 (2019): 5768-5776. https://doi.org/10.3892/ol.2019.10260